Previous 10 | Next 10 |
SALT LAKE CITY, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and full year 2021 operating results on Tuesday, March 1, ...
Palm Beach, FL – January 20, 2022 – FinancialNewsMedia.com News Commentary – Cloud computing increases real-time data collection and improves accessibility to the data. It has outpaced the conventional paper healthcare system by providing more speed and effi...
Jefferies has initiated coverage of Health Catalyst (NASDAQ:HCAT) with a hold amid concerns over growing competition and profitability. Analyst Glen Santangelo has a $48 price target (~17% upside). While Santangelo says the company's data and analytics platform provides a good value propositi...
Health Catalyst Partners with Datavant to Expand Access to Clinical Trials as a Care Option for Patients PR Newswire SALT LAKE CITY and SAN FRANCISCO , Nov. 16, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider o...
Image source: The Motley Fool. Health Catalyst Inc (NASDAQ: HCAT) Q3 2021 Earnings Call Nov 09, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Health Catalyst Inc (HCAT) Q3 2021 Earnings Call Transcript
Health Catalyst, Inc. (HCAT) Q3 2021 Earnings Conference Call November 9, 2021 17:00 ET Company Participants Adam Brown - Investor Relations Dan Burton - Chief Executive Officer Bryan Hunt - Chief Financial Officer Conference Call Participants Anne Samuel - JPMorgan Jessica Tassan - Piper San...
SALT LAKE CITY, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2021. ...
Health Catalyst (NASDAQ:HCAT) is scheduled to announce Q3 earnings results on Tuesday, November 9th, after market close. The consensus EPS Estimate is -$0.22 (-4.8% Y/Y) and the consensus Revenue Estimate is $60.82M (+28.9% Y/Y). Over the last 2 years, HCAT has beaten EPS estimates 100% of th...
SALT LAKE CITY, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its 2021 third quarter operating results on Tuesday, November 9, 2021, after ...
Palm Beach, FL – October 19, 2021 – FinancialNewsMedia.com News Commentary – The COVID-19 pandemic has resulted in social distancing and lockdowns. This has led to a shortage of manpower as a consequence of imposed shutdowns. This has necessitated the implem...
News, Short Squeeze, Breakout and More Instantly...
Health Catalyst Announces New Credit Facility for up to $225,000,000 PR Newswire SALT LAKE CITY , July 18, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company") (Nasdaq: HCAT), a leading provider of data and analytics technology and...
2024-07-01 07:30:03 ET Wells Fargo analyst issues OVERWEIGHT recommendation for HCAT on July 1, 2024 06:12AM ET. The previous analyst recommendation was Overweight. HCAT was trading at $6.39 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...